secwatch.observer — SEC 8-K summary
======================================

Issuer:     FIREFLY NEUROSCIENCE, INC. (AIFF)
CIK:        0000803578
Form:       8-K
Filed at:   2024-11-15T23:59:59+00:00
Accession:  0001437749-24-035398
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Firefly Neuroscience Q3 cash $1.2M; partners with Bright Minds, Novartis, Takeda
--------------------------------------------------------------------------------

- Cash $1.2M as of Sept 30, 2024; shares outstanding 8,503,365 as of Nov 12.
- Partnered with Bright Minds, Novartis, Takeda for BNA platform in drug development.
- Integrated BNA technology at Neurology Consultants of Dallas; partnered with Zeto for EEG devices.
- Appointed Dr. Stella Vnook to Board of Directors.
- Completed merger with WaveDancer; listed on Nasdaq under ticker AIFF.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/803578/000143774924035398/0001437749-24-035398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/803578/000143774924035398/wavd20241112_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-035398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer